| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 135 | 17.979 | 27.492 | 61.103 | 54.489 | 51.891 | 66.965 | 72.326 | 69.095 | 73.792 |
| Total Income - EUR | 135 | 17.983 | 27.492 | 61.105 | 54.492 | 51.918 | 69.036 | 72.494 | 69.139 | 73.849 |
| Total Expenses - EUR | 0 | 14.747 | 16.407 | 24.331 | 30.608 | 35.986 | 38.841 | 36.171 | 41.634 | 48.221 |
| Gross Profit/Loss - EUR | 135 | 3.236 | 11.085 | 36.774 | 23.884 | 15.932 | 30.195 | 36.323 | 27.505 | 25.628 |
| Net Profit/Loss - EUR | 131 | 2.876 | 10.810 | 36.163 | 23.383 | 15.586 | 29.576 | 35.613 | 26.896 | 23.678 |
| Employees | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dermaclas Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 1.470 | 2.982 | 15.019 | 12.180 | 9.532 | 5.012 | 5.184 | 4.186 | 15.607 |
| Current Assets | 180 | 1.903 | 9.257 | 32.513 | 62.681 | 79.896 | 48.339 | 84.672 | 69.608 | 73.729 |
| Inventories | 0 | 0 | 0 | 0 | 168 | 165 | 0 | 10 | 0 | 0 |
| Receivables | 0 | 1.503 | 3.362 | 4.113 | 7.726 | 4.156 | 6.133 | 27.616 | 8.033 | 7 |
| Cash | 180 | 400 | 5.895 | 28.401 | 54.786 | 75.575 | 42.206 | 57.046 | 61.575 | 73.722 |
| Shareholders Funds | 176 | 3.050 | 10.862 | 46.826 | 42.683 | 57.461 | 44.865 | 35.662 | 40.965 | 64.413 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4 | 362 | 1.433 | 800 | 32.258 | 32.069 | 8.552 | 54.270 | 32.932 | 24.970 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermaclas Srl